Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition
Timothy R. Bishop, Chitra Subramanian, Eric M. Bilotta, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1215-1222
Open Access | Times Cited: 19

Showing 19 citing articles:

HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription
Ziping Niu, Chen Chen, Siyu Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Coenzyme A biosynthesis: mechanisms of regulation, function and disease
Samuel A. Barritt, Sarah DuBois-Coyne, Christian C. Dibble
Nature Metabolism (2024) Vol. 6, Iss. 6, pp. 1008-1023
Closed Access | Times Cited: 18
Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
Qi Chang, Jiayi Li, Yue Deng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2466-2486
Closed Access | Times Cited: 14
Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
Xiaokang Chen, Hao Wu, Ya Liu, et al.
Circulation (2024) Vol. 149, Iss. 20, pp. 1598-1610
Closed Access | Times Cited: 9
Mechanisms of metabolism-coupled protein modifications
Bingsen Zhang, Frank C. Schroeder
Nature Chemical Biology (2025)
Closed Access | Times Cited: 1
Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia
Yujun Chen, Yu Zhao, Mingyue Yao, et al.
Acta Pharmacologica Sinica (2025)
Open Access | Times Cited: 1
Development of p300-targeting Degraders with enhanced selectivity and onset of degradation
Graham P. Marsh, Mark S. Cooper, Sean Goggins, et al.
RSC Medicinal Chemistry (2025)
Open Access
Augmented Acyl-CoA Biosynthesis Promotes Resistance to TEAD Palmitoylation Site Inhibition
Kayla Nutsch, Marissa N. Trujillo, Lirui Song, et al.
ACS Chemical Biology (2025)
Closed Access
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
Lizhen Liu, Peng Deng, Sai‐Lan Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 7
Paralogue-Selective Degradation of the Lysine Acetyltransferase EP300
Xuemin Chen, McKenna C. Crawford, Ying Xiong, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 3094-3103
Open Access | Times Cited: 2
Targeting lysine acetylation readers and writers
Ming‐Ming Zhou, Philip A. Cole
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 2
Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors
McKenna C. Crawford, Deepika R. Tripu, Samuel A. Barritt, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 10, pp. 2249-2258
Open Access | Times Cited: 5
Pyrimidine synthesis enzyme CTP synthetase 1 suppresses antiviral interferon induction by deamidating IRF3
Youliang Rao, Chao Qin, Ali Can Savas, et al.
Immunity (2024)
Closed Access | Times Cited: 1
TMEM120A-mediated regulation of chemotherapy sensitivity in colorectal cancer cells
Li Wang, Xiaoxia Liu
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 1, pp. 11-22
Closed Access | Times Cited: 3
Small-molecule tools for YEATS domain proteins
Michael A. Erb
Current Opinion in Chemical Biology (2023) Vol. 77, pp. 102404-102404
Open Access | Times Cited: 3
Paralogue-selective degradation of the lysine acetyltransferase EP300
Xuemin Chen, McKenna C. Crawford, Ying Xiong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
McKenna C. Crawford, Deepika R. Tripu, Samuel A. Barritt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Cpt1a Drives primed-to-naïve pluripotency transition through lipid remodeling
Zhaoyi Ma, Xingnan Huang, Junqi Kuang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Metabolic regulation of epigenetic drug resistance
Nathaniel W. Snyder, Jordan L. Meier
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1174-1175
Closed Access
Page 1

Scroll to top